Stephen J. Hunt, MD, PhD, FSIR (he/him/his)

Associate Professor
University of Pennsylvania, United States

Presentation(s):

• 70 - Utility of Alpha-Fetoprotein (AFP) monitoring after Y-90 radioembolization of hepatocellular carcinoma in non-AFP producers

  Monday, March 31, 2025
  12:10 PM – 1:10 PM CT

• 82 - Drain for life? Outcomes of Percutaneous Drainage of Malignancy-Associated Abscesses

  Monday, March 31, 2025
  12:10 PM – 1:10 PM CT

• New Ablation Techniques: Boom or Bust? - PEF

  Tuesday, April 1, 2025
  1:55 PM – 2:00 PM CT

• A Single Institutional Experience with Pulsed Electric Field Ablation in the Treatment of Patients with Localized and Metastatic Cancer

  Tuesday, April 1, 2025
  3:00 PM – 3:09 PM CT

• Influence of Sarcopenia and Myosteatosis on Outcomes from Lung Ablation

  Tuesday, April 1, 2025
  3:45 PM – 3:54 PM CT

• Pilot Randomized Trial of Transarterial Chemoembolization With or Without Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients Awaiting Transplantation

  Tuesday, April 1, 2025
  4:12 PM – 4:21 PM CT

• Premedication with NK-1 antagonists and COX-2 inhibitors improves same day discharge rates following chemoembolization for hepatocellular carcinoma and neuroendocrine liver metastasis

  Tuesday, April 1, 2025
  4:21 PM – 4:30 PM CT

• Pulse Electrical Field ablation data in lungs and soft tissue

  Tuesday, April 1, 2025
  4:15 PM – 4:24 PM CT